Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,822,774
  • Shares Outstanding, K 227,752
  • Annual Sales, $ 1,870 M
  • Annual Income, $ 359,190 K
  • 60-Month Beta 0.29
  • Price/Sales 5.79
  • Price/Cash Flow 15.31
  • Price/Book 3.87
Trade QGEN with:

Options Overview

Details
  • Implied Volatility 41.35%
  • Historical Volatility 29.55%
  • IV Percentile 68%
  • IV Rank 59.63%
  • IV High 59.11% on 02/08/21
  • IV Low 15.13% on 03/10/20
  • Put/Call Vol Ratio 6.75
  • Today's Volume 31
  • Volume Avg (30-Day) 454
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 251
  • Open Int (30-Day) 18,220

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.63
  • Number of Estimates 5
  • High Estimate 0.64
  • Low Estimate 0.61
  • Prior Year 0.34
  • Growth Rate Est. (year over year) +85.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.20 +0.11%
on 03/08/21
56.21 -17.72%
on 02/12/21
-9.53 (-17.08%)
since 02/08/21
3-Month
46.20 +0.11%
on 03/08/21
59.00 -21.61%
on 02/08/21
-4.10 (-8.14%)
since 12/08/20
52-Week
36.16 +27.90%
on 03/18/20
59.00 -21.61%
on 02/08/21
+4.68 (+11.26%)
since 03/06/20

Most Recent Stories

More News
QIAGEN (QGEN) Unveils Digital Platform for Syndromic Testing

QIAGEN's (QGEN) QIAsphere cloud-based platform will enhance QIAstat-Dx's potential by offering remote services round the clock to improve testing continuity.

ACOR : 5.17 (-0.96%)
QGEN : 46.25 (-2.67%)
CLSD : 2.95 (-6.65%)
AVIR : 58.81 (-1.95%)
QIAGEN Announces 20-F Annual Report Filing for 2020 Results

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December...

QGEN : 46.25 (-2.67%)
QIAGEN (QGEN) Launches QIAcube Connect MDx Platform Globally

QIAGEN's (QGEN) QIAcube Connect MDx platform can be used with more than 140 standard protocols and it ensures complete consistency of the purification of multiple sample types.

ACOR : 5.17 (-0.96%)
QGEN : 46.25 (-2.67%)
CLSD : 2.95 (-6.65%)
AVIR : 58.81 (-1.95%)
QIAGEN Launches QIAcube Connect MDx Platform for Automated Sample Processing in Diagnostic Labs

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of the QIAcube Connect MDx, a flexible platform for automated sample processing that will now be available to molecular...

QGEN : 46.25 (-2.67%)
Global Green Tea Market Size & Share Will Reach USD 20,000 Million By 2026: Facts & Factors

Facts and Factors have published a new research report titled "Green Tea Market By Type (Iced Green Tea, Green Tea Bags, Loose-Leaf, Green Tea Instant Mixes, and Others), By Flavor (Basil, Lemon, Cinnamon,...

QGEN : 46.25 (-2.67%)
TECH : 344.88 (-3.18%)
Exosome Research Products Market Size Will Exceed USD 325.5 Million by 2026, Globally: Facts & Factors

Facts and Factors have published a new research report titled "Exosome Research Products Market By Product and Service (Instruments, Reagents & Kits, and Services); by Application (Cancer and Non-Cancer...

QGEN : 46.25 (-2.67%)
TECH : 344.88 (-3.18%)
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

and GERMANTOWN, Md. and HILDEN, , /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a...

QGEN : 46.25 (-2.67%)
INO : 8.91 (-3.05%)
QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO's VGX-3100 for Advanced Cervical Dysplasia

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid...

QGEN : 46.25 (-2.67%)
INO : 8.91 (-3.05%)
Global Oncology Molecular Diagnostics Market Report 2020-2030: Major Players are Abbott Diagnostics, BD, Cepheid, Danaher, Beckman Coulter, Leica Biosystems, Gen Probe, Qiagen, Roche, Siemens

, /PRNewswire/ -- The report has been added to offering.

CPHD : 52.95 (unch)
HOLX : 70.91 (-1.99%)
ICLR : 180.22 (+0.22%)
QGEN : 46.25 (-2.67%)
NEOGEN's (NEOG) New Test to Identify Coronavirus in Wastewater

Launch of NEOGEN's (NEOG) latest test, which marks its entry into wastewater testing, is expected to become a key tool to combat COVID-19.

HOLX : 70.91 (-1.99%)
QGEN : 46.25 (-2.67%)
NEOG : 79.34 (-0.51%)
IDXX : 482.60 (-3.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

3rd Resistance Point 48.07
2nd Resistance Point 47.68
1st Resistance Point 46.97
Last Price 46.25
1st Support Level 45.87
2nd Support Level 45.48
3rd Support Level 44.77

See More

52-Week High 59.00
Fibonacci 61.8% 50.28
Fibonacci 50% 47.58
Last Price 46.25
Fibonacci 38.2% 44.88
52-Week Low 36.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar